---
title: "LENSAR holds annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295445210.md"
description: "LENSAR held its annual shareholder meeting on August 4, 2026. Key outcomes included the election of Thomas B. Ellis, Richard L. Lindstrom, MD, and William J. Link, PhD as Class III directors. The company also ratified PwC as its independent registered public accounting firm for the fiscal year ending December 31, 2026, and established an annual schedule for future say-on-pay advisory votes."
datetime: "2026-08-10T20:18:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295445210.md)
  - [en](https://longbridge.com/en/news/295445210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295445210.md)
generator: "portal-rs"
---

# LENSAR holds annual shareholder meeting

-   LENSAR held its annual shareholder meeting on Aug. 4, 2026. \* Shareholders elected Thomas B. Ellis, Richard L. Lindstrom, MD, and William J. Link, PhD as Class III directors. \* PwC’s appointment was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. \* Advisory vote set future say-on-pay votes on an annual schedule. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LENSAR Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-342330), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [LNSR.US](https://longbridge.com/en/quote/LNSR.US.md)

## Related News & Research

- [LENSAR posts investor presentation highlighting ALLY robotic laser cataract surgery platform](https://longbridge.com/en/news/296134599.md)
- [LENSAR Q2 FY26 net income turns to USD 3.5 million; revenue rises 18% to USD 16.5 million](https://longbridge.com/en/news/295786278.md)
- [FS KKR Capital hosts shareholder meeting on share issuance proposal vote](https://longbridge.com/en/news/296534123.md)
- [Tempest Therapeutics special meeting adjourned after proposal fell short of required votes](https://longbridge.com/en/news/296266762.md)
- [NurExone Biologic announces annual general and special shareholder meeting](https://longbridge.com/en/news/296365329.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**